Securities code: 000788 securities abbreviation: Pku Healthcare Corp.Ltd(000788) Announcement No.: 2022-006 Pku Healthcare Corp.Ltd(000788)
Announcement on receiving the warning letter from Chongqing Securities Regulatory Bureau and the decision of the company’s relevant personnel on the supervision measures of Chongqing Securities Regulatory Bureau
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Pku Healthcare Corp.Ltd(000788) (hereinafter referred to as the company) received the decision on Issuing warning letter for Pku Healthcare Corp.Ltd(000788) (No. [2022] 6) (hereinafter referred to as the “warning letter”) issued by Chongqing regulatory bureau of China Securities Regulatory Commission (hereinafter referred to as “Chongqing Securities Regulatory Bureau”) on January 29, 2022 The relevant information of the decision on taking regulatory talk measures against Pku Healthcare Corp.Ltd(000788) song Jinsong, Yuan Pingdong and Yuan Yufei ([2022] No. 7) (hereinafter referred to as the “decision on regulatory talk measures”) is hereby announced as follows:
1、 Main contents of warning letter
On June 3, 2019, your company signed the maximum guarantee contract with Bank Of Nanjing Co.Ltd(601009) to provide guarantee for the loan of Bank Of Nanjing Co.Ltd(601009) 100 million yuan from Peking University Medical Industry Group Co., Ltd. (hereinafter referred to as “Peking University Medical”) for the period from June 5, 2019 to June 5, 2020. On June 4, 2020, Peking University Medical and Bank Of Nanjing Co.Ltd(601009) reached an extension plan and signed the loan extension agreement, which will be extended to June 4, 2021. Your company signed the letter of guarantee for loan extension on July 1, 2021. On August 9, 2021, your company received the notice of Bank Of Nanjing Co.Ltd(601009) urging the performance of the guarantee responsibility issued by Bank Of Nanjing Co.Ltd(601009) , saying that the above-mentioned loan of Peking University Medical has been overdue, and it still owes 100 million yuan of the loan principal and the interest, default interest, compound interest and the cost of realizing the creditor’s rights agreed in the contract. Your company is required to raise funds to perform the guarantee responsibility as soon as possible, or urge the borrower to repay the loan principal and interest. Your company failed to timely fulfill the obligation of information disclosure on major events with the risk of fulfilling the guarantee responsibility, and it will not be disclosed until January 22, 2022.
The above acts violate the relevant provisions of Articles 3 and 22 of the measures for the administration of information disclosure of listed companies (Order No. 182 of the CSRC, hereinafter referred to as the “measures for the administration of information disclosure”). In accordance with Article 52 of the measures for the administration of information disclosure, our bureau has decided to take administrative supervision measures to issue warning letters to your company and record them in the integrity archives of the securities and futures market. Your company shall effectively strengthen the management of information disclosure affairs to ensure the true, accurate, complete, timely and fair performance of information disclosure obligations.
2、 Main contents of the decision on regulatory talk measures
On June 3, 2019, Pku Healthcare Corp.Ltd(000788) and Bank Of Nanjing Co.Ltd(601009) signed the maximum guarantee contract to provide guarantee for the loan of Bank Of Nanjing Co.Ltd(601009) 100 million yuan from Peking University Medical Industry Group Co., Ltd. (hereinafter referred to as “Peking University Medical”) for the period from June 5, 2019 to June 5, 2020. On June 4, 2020, Peking University Medical and Bank Of Nanjing Co.Ltd(601009) reached an extension plan and signed the loan extension agreement, which will be extended to June 4, 2021. Pku Healthcare Corp.Ltd(000788) signed the loan extension guarantee letter on July 1, 2021. On August 9, 2021, Pku Healthcare Corp.Ltd(000788) received the notice of Bank Of Nanjing Co.Ltd(601009) urging the performance of the guarantee responsibility issued by Bank Of Nanjing Co.Ltd(601009) , saying that the above-mentioned loan of Peking University Medical has been overdue, and it still owes 100 million yuan of the loan principal and the interest, default interest, compound interest and the cost of realizing the creditor’s rights agreed in the contract, requiring Pku Healthcare Corp.Ltd(000788) to raise funds to perform the guarantee responsibility as soon as possible, or urge the borrower to repay the loan principal and interest. Pku Healthcare Corp.Ltd(000788) failed to timely fulfill the obligation of information disclosure on major events with the risk of fulfilling the guarantee responsibility, and did not disclose it until January 22, 2022.
Pku Healthcare Corp.Ltd(000788) the above acts violate the relevant provisions of Articles 3 and 22 of the measures for the administration of information disclosure. As Pku Healthcare Corp.Ltd(000788) chairman of the board, general manager and Secretary of the board of directors, you should bear the main responsibility for the authenticity, accuracy, integrity, timeliness and fairness of the company’s information disclosure, in violation of articles 4 and 51 of the measures for the administration of information disclosure. In accordance with the provisions of Article 52 of the measures for the administration of information disclosure, our bureau has decided to take administrative supervision measures for your supervision talks and record them in the integrity archives of the securities and futures market. Song Jinsong, Yuan Pingdong and Yuan Yufei are required to bring valid ID cards to Chongqing Securities Regulatory Bureau (16th floor, Hejing building, No. 2 Linjiang Branch Road, Yuzhong District, Chongqing) for regulatory talks at 9 a.m. on February 16, 2022.
3、 Relevant description
1. The board of directors and relevant responsible personnel of the company attach great importance to the problems pointed out in the decision on the above regulatory measures, deeply reflect on the problems and deficiencies existing in the company’s information disclosure, fully learn lessons, and earnestly strengthen the supervision of the securities law of the people’s Republic of China, the measures for the administration of information disclosure of listed companies, the stock listing rules of Shenzhen Stock Exchange Learn relevant laws and regulations such as “standardized operation of companies listed on the main board of Shenzhen Stock Exchange” to further improve the awareness of standardized operation.
2. Previously, the company has issued relevant announcements on the progress of related party guarantee risk resolution. After receiving the notice of Bank Of Nanjing Co.Ltd(601009) urging the performance of guarantee responsibility, the company timely inquired with the controlling shareholder Peking University Medical. After being informed, Founder group and the manager of Founder Group paid close attention to the matter. In order to fully resolve the risk, southwest Synthetic Medicine Group Co., Ltd. provided mortgage guarantee for relevant assets with the coordination and support of the manager of Founder group, Signed the supplementary agreement on counter guarantee contract (II) with the company, and made substantial progress in resolving the related guarantee risk. For details, please refer to the announcement on the progress of related party guarantee risk resolution (2022-005) disclosed by the company on the designated information disclosure media on January 22, 2022.
3. The supervision measures will not affect the normal production, operation and management activities of the company. The company will earnestly perform the obligation of information disclosure and do a good job of information disclosure in a timely manner in strict accordance with the provisions and requirements of relevant laws and regulations. Please pay attention to investment risks.
4、 Documents for future reference
1. Decision on Issuing warning letter for Pku Healthcare Corp.Ltd(000788) ;
2. Decision on taking regulatory talk measures against Pku Healthcare Corp.Ltd(000788) song Jinsong, Yuan Pingdong and Yuan Yufei.
It is hereby announced.
Pku Healthcare Corp.Ltd(000788)
Board of directors
February 7, 2002
